Vi PRP-Pro PRP tubes provide the simplest and most efficient method for obtaining and preparing platelet-rich plasma (PRP) from the patient's blood.
Welcome to a breakthrough in the world of regenerative medicine - the VI PRP-PRO, a PRP tube that will change the way you work with plasma treatments forever. Rely on the latest technology, approved by the latest extension of the EC certificate 0425-MED-004180-00, to take your practice to the next level.
1) Certified as risk class IIa medical devices:
According to the provisions of Directive 93/42/EEC on medical devices, consumables used for the preparation of plasma for therapeutic purposes must meet certain requirements. In particular, plasma preparation by centrifugation requires tubes that are classified and certified as medical devices in risk class IIa. However, in order to ensure maximum safety for the end user, some manufacturers certify these tubes as risk class IIa medical devices, which requires additional risk analyses and clinical studies of the product.
2) They contain a special separating gel. The most important physico-chemical and biological properties of this gel are
(a) biocompatibility/hemocompatibility;
(b) long-term stability in contact with the anticoagulant;
(c) thixotropy;
(d) well-defined density.
Anticoagulant: Sodium citrate 0.8 ml, sodium citrate PH 6.5 / 7
Approximately 4 / 4.5 ml of PRP can be obtained in each PRP tube.
PRP-PRO is a modular medical product that is used to produce platelet-rich plasma (PRP).
It has the following properties:
The VI PRP-PRO tube is specially designed for the preparation of Class IIa autologous platelet-rich plasma (PRP). Its revolutionary technology enables efficient and concentrated collection of PRP, making it the ideal choice for advanced therapeutic applications.
The most recent approval, recorded in the document D-BIOTECH S.R.L. SEMPLIFICATA_variazione_22 11 2023.pdf, attests that the VI PRP-PRO tube meets all strict EU requirements according to Article 120(3) of the MDR. This approval ensures that any change has been classified as non-significant - a sign of reliability and trustworthiness.
With the VI PRP-PRO, you can rely on innovation. Whether for aesthetic treatments, orthopaedic therapies or wound healing, this tube is designed to deliver optimal results. The new commercial variants that have now been approved mean that you can offer your patients the latest and most effective treatment.
The VI PRP-PRO is extremely easy to use. It is designed to integrate seamlessly into your existing clinical processes. This means less time spent preparing and more time with your patients. See for yourself how the VI PRP-PRO increases the efficiency and effectiveness of your treatments.
As part of the new product line highlighted in the official letter from ICIM S.p.A., the VI PRP-PRO tube represents a commitment to excellence. It represents not only an extension of approval, but also an ongoing commitment to deliver the best medical solutions.
PRP-PRO - PRP tubes enable the simple, safe and fast preparation of blood components (e.g. platelet gel, fibrin gel, bone marrow cell gel) and are intended for the use of autologous blood products.
The reason for using this medical device is to administer locally high concentrations of growth factors as found in platelet concentrate. It may also provide cells that are involved in repair or support tissue and temporary fibrin scaffolding and cell migration.
The PRP tubes must be used by specially trained medical personnel and possibly under medical supervision.
The therapeutic efficacy depends on the intrinsic quality and preparation of the blood components. This medical device enables the production and
Activation (gelling) of the blood components. PRP-PRO is not therapeutic in itself. The most important indications for the use of this
Medical device is the treatment of acute wounds, chronic skin ulcers, subcutaneous or mucocutaneous tissue and bone injuries, subcutaneous injections/fillers and strengthening of hair roots.
The method based on this preparation is called "BUFFY COAT" and requires PRP tubes that differ from the "EMPTY TEST" (simple vacuum blood collection tube), which does not produce a concentrate but a serum. These tubes are not able to sediment the blood with high precision and produce a high PRP concentration. Furthermore, they do not allow only the intermediate layer (PRP) to be extracted.
In addition, the plastic of the simple vacuum blood collection tubes contains micronized silicone, which can also produce platelet activation. All this results in a platelet-free serum after the centrifugation process, which cannot be used for PRP.
PRP-PRO are not made of plastic and do not contain micronized silicone!
The composition is optimally balanced to achieve maximum biological effect. Platelet-rich plasma (PRP) is also known as platelet autologous platelet gel, growth factor-rich plasma (PRGF) or platelet concentrate (PC). It is essentially an increase in the concentration of autologous platelets contained in a small amount of plasma after centrifugation of the patient's blood.
The PRP tubes are available in the following vacuum capacities: 9ml.
The production of PRP consists of the collection of autologous venous blood (from the patient to be treated), which is then centrifuged and concentrated (method called BUFFY COAT).
After blood collection, centrifugation (rotation/centrifugal force depending on the centrifuge) is performed until three layers are obtained:
Set the centrifuge to the following parameters:
1200 RCF (g) (For Hettich EBA 200 to 3400 rpm) for 7 minutes for angled or inclined rotor centrifuges.
To determine the relative centrifugal force (RCF), or to calculate the revolutions per minute (RPM), you can use our converters.
RCF/RPM CONVERTER
https://www.hettichlab.com/de/rpmrcf-umrechner/
Reconstruction of the lower jaw, dental implants, tonal and oropharyngeal fissures;
Neck and head surgery, facial or nasal fractures;
Lesions of the dental alveoli; breast augmentation; reconstruction of the lower jaw; bone graft; oronasal fistula; lip repair; rhinoplasty and septal rhinoplasty; facial fractures
Skin flaps, muscle-skin reconstructions, mammoplasty; face and neck lift; musculocutaneous flaps and reconstruction; chronic ulcers; breast reconstruction and mammoplasty; craniofacial reconstruction; adjunct for laser facial treatments
Pseudoarthrosis, osteosynthesis, bone implants, titanium prosthesis implants
Vertebral reconstruction; burr holes and craniectomy; cerebrospinal fluid loss
Sternal repair; arterial bypass; arterial reconstruction; broncho-pleural fistula
Corneal ulcers and wounds; repair of macular lesions (with hyperconcentrated platelets).
Regeneration of the hair roots
are specialized areas in which ulcers or acute or chronic ruptures, primary or secondary, could find therapeutic support in the use of platelet gel.
The PRP-PRO PRP tube is a medical device that should only be used by qualified professionals and can only be used safely under certain conditions.
It should be used with particular caution in patients suffering from acute or chronic infections, uncontrolled metabolic diseases such as diabetes, osteomalacia or thyroid dysfunction, severe kidney or liver disease, autoimmune diseases or radiotherapy. Patients with congenital or acquired functional platelet defects may release fewer growth factors, making it difficult to obtain a platelet-rich concentrate for clinical use.
Platelet-derived growth factors can stimulate cell proliferation. The use of the platelet gel is contraindicated in suspected malignant degenerative lesions and it should only be introduced into vital tissue and in direct contact with the tissue (if necessary, through micro-openings on the surface of the tissue) to ensure tissue regeneration.
By following the instructions for use, the PRP-PRO PRP tube can be used to produce platelet-rich plasma (PRP) with a platelet concentration 4-5 times higher than the original blood (1 x 106 platelets/microliter ± 20%).
The PRP contains mainly passively released growth factors and chemotactic mediators from the platelets, which is why it can be produced from the blood of patients taking oral anticoagulants, heparin, calcium heparin, antiplatelet agents or cyclooxygenase inhibitors.
However, it could be that part of the release of growth factors depends on the activation state of the platelets.
Important note:
As the seller, we would like to point out that the injection of products with and without lidocaine should only be carried out by trained and medically qualified personnel in the medical and nursing field.
Save products on your wishlist to buy them later or share with your friends.